Animal research has showed unchanged EGF levels in the brain or serum following long-term administration of typical antipsychotic agents haloperidol, which adds to the evidence that antipsychotics and ECT would not improve psychiatric symptoms via increasing EGF levels in adults with schizophrenia. The gene discussed is EGF; the disease is schizophrenia.